Leukemia, Myelocytic, Acute
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Somatic mutation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neoplasm, Residual
|
0.050 |
GeneticVariation
|
phenotype |
BEFREE |
Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.
|
12139724 |
2002 |
Granulocytic Sarcoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
|
16504290 |
2006 |
Sarcoma of mesentery
|
0.010 |
Biomarker
|
disease |
BEFREE |
Granulocytic sarcoma of mesentery in acute myeloid leukemia with CBFB/MYH11 fusion gene but not inv(16) chromosome: case report and review of literature.
|
16504290 |
2006 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
AML with the CBFB/MYH11 fusion gene but without inv(16) was found in M2, M4, and M5, but not in M4E patients.
|
17052753 |
2007 |
Acute monocytic leukemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
AML with the CBFB/MYH11 fusion gene but without inv(16) was found in M2, M4, and M5, but not in M4E patients.
|
17052753 |
2007 |
Acute myeloid leukemia, inv(16)(p13q22)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
|
20513535 |
2010 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
|
23236551 |
2013 |
Core binding factor acute myeloid leukemia
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Core Binding Factor acute myeloid leukemia (CBF-AML) with t(8;21) RUNX1-MTG8 or inv(16) CBFB-MYH11 fusion proteins often show upregulation of wild type or mutated KIT receptor.
|
25612891 |
2015 |
Core binding factor acute myeloid leukemia
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Core-binding factor acute myeloid leukemia (CBF-AML) is defined by the presence of either t(8;21)(q22;q22)/RUNX1-RUNX1T1 or inv(16)(p13.1q22)/t(16;16)(p13.1;q22)/CBFB-MYH11.
|
27843138 |
2017 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
AML with CBFB-MYH11, RUNX1-RUNX1T1, mutated NPM1, and FLT3-ITD were excluded and accrued to genotype-specific trials.
|
30728457 |
2019 |
Acute monocytic leukemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
AML with CBFB-MYH11, RUNX1-RUNX1T1, mutated NPM1, and FLT3-ITD were excluded and accrued to genotype-specific trials.
|
30728457 |
2019 |
leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
CBFB is associated with human leukemias through a chromosome 16 inversion and is essential for definitive hematopoiesis during mouse embryo development.
|
11110689 |
2000 |
Leukemogenesis
|
0.100 |
PosttranslationalModification
|
disease |
BEFREE |
PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.
|
18695000 |
2008 |
Leukemia, Myelocytic, Acute
|
0.500 |
Biomarker
|
disease |
BEFREE |
CBFB and MYH11 in inv(16)(p13q22) of acute myeloid leukemia displaying close spatial proximity in interphase nuclei of human hematopoietic stem cells.
|
21638519 |
2011 |
Hepatitis B
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CBFβ expression was lower in HBV patients than in healthy persons, and the addition of serum from HBV patients inhibited CBFβ expression in HepG2 cells.
|
29523836 |
2019 |
Leukemia, Myelocytic, Acute
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A common mutation in AML is the inversion of chromosome 16 [inv (16)], which generates a fusion between the genes for core binding factor beta (<i>CBFB)</i> and smooth muscle myosin heavy chain gene (<i>MYH11</i>), forming the oncogene <i>CBFB-MYH11</i>.
|
30814129 |
2019 |
Leukemia, Myelocytic, Acute
|
0.500 |
Biomarker
|
disease |
BEFREE |
A fusion between the transcription factor core-binding factor beta (CBF beta; also known as PEBP2 beta) and the tail region of smooth muscle myosin heavy chain (SMMHC) is generated by an inversion of chromosome 16 [inv(16) (p13q22)] associated with the M4Eo subtype of acute myeloid leukemia.
|
7651416 |
1995 |
Congenital chromosomal disease
|
0.040 |
GeneticVariation
|
group |
BEFREE |
A total of nine well-defined chromosome aberrations with fusion gene transcripts were selected: t(1;19) with E2A-PBX1, t(4;11) with MLL-AF4, t(8;21) with AML1-ETO, t(9;22) with BCR-ABL p190 and BCR-ABL p210, t(12;21) with TEL-AML1, t(15;17) with PML-RARA, inv (16) with CBFB-MYH11, and microdeletion 1p32 with SIL-TAL1.
|
10602411 |
1999 |
Acute myelomonocytic leukemia
|
0.550 |
Biomarker
|
disease |
CTD_human |
A unique structural abnormality of chromosome 16 resulting in a CBF beta-MYH11 fusion transcript in a patient with acute myeloid leukemia, FAB M4.
|
10958941 |
2000 |
Congenital chromosomal disease
|
0.040 |
GeneticVariation
|
group |
BEFREE |
Acute myeloid leukemia patients with recurrent cytogenetic abnormalities including inv(16);CBFB-MYH11 and t(15;17);PML-RARA may be assessed by monitoring the levels of the corresponding abnormal fusion transcripts by quantitative reverse transcription-PCR (qRT-PCR).
|
26079545 |
2015 |
leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although CBFB forms a core-binding factor transcriptional complex with RUNX1, previous analyses have excluded the CBFB gene as the leukemia-predisposing gene in these families.
|
15334552 |
2004 |
Childhood Leukemia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although CBFB forms a core-binding factor transcriptional complex with RUNX1, previous analyses have excluded the CBFB gene as the leukemia-predisposing gene in these families.
|
15334552 |
2004 |